Tg(Ext2*D227N,lacZ)M13Tsh
Transgene Detail
|
|
| Symbol: |
Tg(Ext2*D227N,lacZ)M13Tsh |
| Name: |
transgene insertion M13, Takuji Shirasawa |
| MGI ID: |
MGI:3698184 |
| Synonyms: |
Tg(Ext2(ASP227ASN),lacZ)M13Tsh, TgEXT2(D227N)/lacZ |
| Transgene: |
Tg(Ext2*D227N,lacZ)M13Tsh Location: unknown
|
| Alliance: |
Tg(Ext2*D227N,lacZ)M13Tsh page
|
|
|
|
| Transgene Type: |
|
Transgenic (Inserted expressed sequence) |
| Mutation: |
|
Insertion
|
| |
|
Tg(Ext2*D227N,lacZ)M13Tsh expresses
1 gene
Transgene expresses:
| Organism |
Expressed Gene |
Note |
| mouse |
Ext2 (MGI:108050) |
|
|
| |
|
Mutation details: Two co-injected transgene constructs both employ the regulatory sequences of the mouse procollagen, type XI, alpha 2 (Col11a2) gene, in a DNA fragment encompassing nucleotides -742 through +380 (relative to the transcription start site), to direct expression to developing chondrocytes. One construct contains a full-length, 2.2-kb cDNA encoding a mutant mouse exostoses (multiple) 2 protein with the hereditary multiple exostoses- (HME-) associated aspartic acid-to-asparagine substitution at amino acid position 227, followed by the SV40 splice donor/acceptor and polyadenylation signal. In the second construct, the mouse cDNA is replaced by the E. coli beta-galactosidase (lacZ) coding sequence.
(J:48125, J:75965)
|
|
|
| Mouse strains and cell lines
available from the International Mouse Strain Resource
(IMSR) |
| Carrying this Mutation: |
Mouse Strains: 1 strain available
Cell Lines: 0 lines available
|
|
|
Embryonic and adult mice of 3 high-copy number transgenic lines were analyzed; no distinction was made among them.
|
| Original: |
J:75965 Morimoto Ki K, et al., Transgenic Expression of the EXT2 Gene in Developing Chondrocytes Enhances the Synthesis of Heparan Sulfate and Bone Formation in Mice. Biochem Biophys Res Commun. 2002 Apr 12;292(4):999-1009 |
| All: |
2 reference(s) |
|